|
INVITED
LECTURES AT MAJOR INTERNATIONAL MEETINGS & CENTRES
(Last 10 years only listed)
1994
Invited Symposium Speaker
International Meeting on Lung Tumours, European School of Oncology,
Sydney, September. "Aetiology and pathogenesis of Mesothelioma".
Invited Symposium Speaker
European Respiratory Society Annual Scientific Meeting, Nice,
France, October. "Basic Biology of Mesothelioma".
Invited Symposium Speaker
World Congress on Lung Cancer, Colorado Springs, USA. "Early
Staging of Mesothelioma and Clinical Symptoms in the Staging of
Mesothelioma".
1995
Invited Symposium Speaker and Chairman
International Mesothelioma Conference, Paris, France. September
1995. "Immunology of Mesothelioma" and "Potential
for Gene Therapy of Mesothelioma".
Invited Lecture
Gene Therapy Inc., Gathersburg, Maryland, USA. September
1995
"Gene Therapy of Mesothelioma".
Invited Lecture
University of Maryland, Maryland, USA. September 1995
"MHC Molecules and Immune Recognition of Tumours".
Invited Lecture
Dept of Oncology, Johns Hopkins Medical School, Baltimore, Maryland,
USA. September 1995.
"Co-stimulation, Immune Recognition and Immune Deviation
in Tumour Immunology".
Invited Lecture
National Cancer Institute, Frederick, Maryland, USA. September
1995.
"Immune Deviation, Co-stimulation and Antisense Inhibition
in Tumour Immunology"
Invited Symposium Speaker
Asbestos Medico-Legal Conference, Sydney, Australia, November
1995.
"Cytokines and the Molecular Biology of Mesothelioma".
1996
Invited Symposium Speaker
10th International Biotechnology Symposium, Sydney.
"Gene therapy of cancer".
Invited Speaker
Asia Pacific Society of Respirology, Beijing.
"Immune responses in the lung".
Invited Speaker
Biomedical Research Centre, Vancouver, BC.
"Gene transfer and antisense approaches to cancer".
1997
Invited Lecturer
Australasian College of Physical Scientists and Engineers in Medicine,
Annual Scientific Meeting, Perth, Australia.
"Research in a teaching hospital".
Invited Speaker & Co-Chairman
International Mesothelioma Interest Group Scientific Meeting,
Philadelphia, USA.
"Immunological approaches to gene therapy of mesothelioma".
Invited Symposia Speaker & Co-Chairman
World Lung Cancer Conference, Dublin, Ireland.
"Gene therapy of lung malignancies"
1998
Invited Symposium Speaker and Co-Chair
American Thoracic Society International Conference, Chicago, USA
"Gene therapy of mesothelioma immune approaches"
Invited Speaker
5th Asia-Pacific Congres of Respirology, Sydney, Australia.
"Basic aspects of lung immunology".
Invited Lecture
University of Chicago, Chicago, USA
"Use of TcR transgenics to analyse anti-tumour immune responses".
Invited Lecture
Pittsburgh Cancer Centre, Pittsburgh, USA
"Use of TcR transgenics to analyse anti-tumour immune responses".
Invited Lecture
RPMS, Imperial College, London, UK
"Use of TcR transgenics to analyse anti-tumour immune responses".
1999
Invited Speaker
American Thoracic Society International Conference, San Diego,
April 1999.
"Advanced Techniques in Molecular Biology and Immunology".
2000
Invited Speaker and Workshop Chairman
Keystone Conference on Tumour and Cellular Immunology, Santa Fe,
January 2000.
"Tolerance and anti-tumour immunity".
Invited Symposium Speaker
American Thoracic Society International Conference, Toronto, May
2000.
"TCR Transgenic cells in lung research".
Invited Chairman
American Thoracic Society Postgraduate Course on Advanced Techniques
in Molecular Biology.
Invited Speaker and Workshop Chairman
Keystone Conference on Tumour and Cellular Immunology, Santa Fe,
January 2000.
“Tolerance and anti-tumour immunity”
Invited Symposium Speaker
American Thoracic Society International Conference, Toronto, May
2000.
“TCR Transgenic cells in lung research”.
Invited Chairman
ATS Postgraduate Course on Advanced Techniques in Molecular
Biology.
Invited Speaker
Heidelberg Mesothelioma Conference, Heidelberg, May
”Mesothelioma genetics and therapy”
2003
Invited Speaker
World Lung Cancer Conference, Vancouver BC, May.
“Mesothelioma – new approaches”
Lectures given at San Francisco General Hospital, USA, Berkeley
University, USA, University of Chile, Santiago, Chile, UCLA, Los
Angeles, USA, NIH, Bethesda, MD, USA, RPMS, Imperial College,
London, UK, UCSF, USA, Sir William Dunn School of Pathology,
Oxford University, UK, John Radcliffe Hospital, Oxford, UK,
Biovex, Oxford,UK, Corixa Corp, Seattle, USA, Eli Lilly Corp,
Indianapolis, USA, Pacific Northwest Research Institute,
Seattle, USA, Uni of Washington, Seattle, USA, University of
British Columbia, Vancouver, BC..
2004
Invited lectures/presentations
International Cancer Gene Therapy Conference, Singapore.
International Mesothelioma Conference, Italy
New York University, New York.
Cornell University, New York
Uni of Pennsylvania, Philadelphia
Return to Resume |